Detox can last from a few days to much longer depending on the substance, the severity of dependence and what “detox” actually means in that patient’s treatment plan. A short alcohol or opioid withdrawal-management stay may last several days, while a benzodiazepine taper can continue for weeks or months after the patient leaves a higher-intensity setting. The number of nights in a facility is therefore not the same as the full withdrawal timeline or the full recovery timeline.
The safest duration is based on clinical stabilization, not a fixed package sold in advance. Withdrawal can intensify later than expected, several substances can overlap, and some medications should continue after the acute detox phase rather than being stopped simply because the admission is ending.
Detox Duration at a Glance
| Alcohol | Acute withdrawal often evolves over several days; seizure and delirium risk can extend beyond the first symptoms |
| Short-acting opioids | Withdrawal commonly develops within a day and often improves over roughly a week, though symptoms vary |
| Long-acting opioids | Onset can be later and the withdrawal course longer |
| Benzodiazepines | A safe taper may continue for weeks or months; facility stay and taper duration are not the same |
| Stimulants | Crash and acute stabilization may improve in days while depression, sleep changes and craving persist longer |
| Full addiction treatment | Continues well beyond withdrawal management |
Why Detox Duration Cannot Be Reduced to a Number of Days
Withdrawal duration is shaped by the substance’s pharmacology, half-life, dose pattern and duration of use. It is also shaped by the patient’s age, health, prior withdrawal, liver or kidney function, other substances and the medications used during treatment.
A facility advertising a standard three-, five- or seven-day detox can describe an operational program length, but it cannot guarantee that every patient’s withdrawal biology will match that calendar.
How Detox Duration Changes by Substance
Alcohol
Alcohol withdrawal can begin within hours after alcohol levels fall. Early symptoms such as tremor, anxiety, sweating, insomnia and nausea may appear before the highest-risk complications are fully developed.
Seizures can occur during the early withdrawal period, while alcohol-withdrawal delirium can emerge later. This is why an initially mild presentation does not always justify an immediate assumption that the entire course will stay mild.
The patient can transition out of withdrawal management once the risk has fallen enough for the next setting, even if sleep, anxiety or craving are not completely resolved.
Opioids
Opioid withdrawal timing depends strongly on the opioid. Short-acting opioids tend to produce earlier withdrawal, while long-acting opioids can produce a later and more prolonged course.
SAMHSA TIP 63 describes short-acting opioid withdrawal as beginning within roughly 8-24 hours after last use and commonly lasting around 7-10 days, while long-acting opioid withdrawal can begin later and last 14 days or more.
Those timelines describe withdrawal, not the required duration of a medication-free detox. Buprenorphine or methadone can begin during withdrawal and continue as long-term OUD treatment.
Why fentanyl complicates simple opioid timelines
Illicit fentanyl exposure can be difficult to quantify because dose, frequency and co-exposure are uncertain. Repeated fentanyl use can also complicate the timing of buprenorphine initiation.
Clinical withdrawal signs are therefore more useful than relying on a single hour-count formula copied from a generic opioid timeline.
Benzodiazepines
Benzodiazepines have different half-lives, potency and formulations. Dependence after long-term use is generally managed through an individualized taper rather than abrupt discontinuation.
The 2025 ASAM-led guideline emphasizes gradual dose reduction and adjustment according to patient response. A taper can continue for months in some long-term patients. That does not mean the person needs to remain in an inpatient detox facility for the entire taper.
Stimulants
Cocaine and methamphetamine users may experience an early crash marked by exhaustion, increased sleep, low mood and appetite changes. As the crash improves, craving, depression, anhedonia and cue-triggered urges can continue.
The medical detox question is often shorter than the addiction-treatment question. A patient can be medically stable while still needing intensive stimulant-use-disorder treatment.
Polysubstance use
Different withdrawal syndromes can peak at different times. A person may be improving from opioid withdrawal while benzodiazepine or alcohol risk is still evolving.
Medication interactions also affect discharge timing. Sedating medication used for one withdrawal syndrome can change mental status or fall risk while another syndrome is being monitored.
Admission Length, Withdrawal Length and Recovery Length Are Different
| Admission length | How long the patient stays in a particular withdrawal-management setting |
| Withdrawal length | How long substance-related withdrawal symptoms continue |
| Taper length | How long a gradual medication reduction continues, especially with benzodiazepines |
| Recovery length | Ongoing treatment for addiction, psychiatric symptoms, functioning and relapse prevention |
These timelines overlap but are not interchangeable.
How Clinicians Decide When Detox Should End
Why a longer detox is not automatically better
Once intensive withdrawal monitoring is no longer necessary, keeping someone in acute detox can delay therapy, medication management and recovery work that are better delivered in residential or outpatient treatment.
The goal is not to maximize the number of detox days. It is to match the patient to the right level of care at the right time.
Why a short detox is not automatically better
Rapid discharge can be unsafe when withdrawal is still intensifying, medication has not stabilized, serious psychiatric symptoms remain or the next treatment step is not ready.
A very short stay can also create an avoidable gap between detox and rehab, during which a patient returns home to the same substance access and triggers.
What clinical completion actually means
The patient should be medically stable enough for the next planned setting. Vital signs, mental status and dangerous withdrawal features should be adequately controlled. The patient should also have a realistic medication and follow-up plan.
Detox completion is therefore a clinical transition criterion, not a chemical proof that the body contains no trace of the substance.
Practical Factors That Affect the Length of a Detox Episode
Insurance and authorization
Insurance may authorize withdrawal management separately from residential rehab or other treatment. Providers may need to document ongoing medical necessity if continued high-intensity care is required.
Consumers should ask what happens if coverage changes before the treatment team believes the patient is ready to step down. Financial authorization and clinical readiness are related in practice but should not be confused as the same decision.
Why tapers change the meaning of “detox length”
Benzodiazepine tapering is the clearest example. A patient may spend a short period in a monitored setting and then continue a carefully supervised reduction outpatient.
Opioid medication creates the opposite issue: buprenorphine or methadone should not be tapered merely because a detox stay ended. They may continue as long-term treatment.
Planning time away from work or family
Patients should avoid planning only around an advertised number of detox nights. Transfer into rehab, fatigue, sleep disruption, medication adjustment and psychiatric recovery can extend the time before normal responsibilities are realistic.
A case manager can help estimate the full treatment sequence rather than only the withdrawal stay.
What if withdrawal lasts longer than expected?
Persistent symptoms should trigger reassessment. The person may have prolonged withdrawal, another substance exposure, an untreated medical problem or a psychiatric condition that became more visible after intoxication resolved.
Extending care without reassessment is weaker than identifying why the expected course has changed.
Frequently Asked Questions About Detox Length
How many days is medical detox?
Many acute withdrawal stays last several days, but the safe duration depends on the substance, risk and response to treatment.
Can benzodiazepine detox take months?
A benzodiazepine taper can take weeks or months even though only part of it occurs in a higher-intensity withdrawal setting.
How long is opioid withdrawal?
Short-acting opioid withdrawal commonly lasts about 7-10 days, while long-acting opioids can last 14 days or more. Medication treatment can continue beyond withdrawal.
Can someone leave detox while still having symptoms?
Yes, if remaining symptoms can be safely managed at the next level and dangerous withdrawal has stabilized.
Does a longer detox mean better treatment?
No. Quality depends on appropriate stabilization and transition into continuing addiction treatment, not simply the number of days.
Sources
- SAMHSA Evidence-Based Practices Resource Center: TIP 45, Detoxification and Substance Abuse Treatment: evaluation, stabilization and transition into continuing treatment.
- The ASAM Criteria, Fourth Edition: current person-centered addiction-treatment continuum and integration of intoxication, withdrawal and addiction-medication needs.
- ASAM Criteria: multidimensional level-of-care assessment, withdrawal risk, addiction medication needs and treatment planning.
Alcohol Withdrawal Sources
- ASAM Clinical Practice Guideline on Alcohol Withdrawal Management: ambulatory and inpatient withdrawal management, risk assessment and transition into AUD treatment.
Opioid Treatment Sources
- SAMHSA TIP 63: Medications for Opioid Use Disorder: buprenorphine, methadone and naltrexone as FDA-approved medications for OUD.
- SAMHSA: Provider Information on Treatment Options: medication treatment and overdose-prevention medications.
Benzodiazepine Sources
- Joint Clinical Practice Guideline on Benzodiazepine Tapering, 2025: gradual individualized tapering and avoidance of abrupt discontinuation in physically dependent patients.
About This Article
Editorial standard
Rehabs.Today resource articles are written for educational and treatment-navigation purposes. For medical and drug-safety claims, we prioritize current primary or authoritative references such as FDA and DailyMed labeling, CDC, SAMHSA, NIH/NCBI resources, and peer-reviewed research when appropriate. Important limitations, uncertainty, and differences between population-level evidence and individual medical advice are stated where they matter.
How to use this information
This article provides general educational information. It is not a diagnosis, prescription, personalized taper, or substitute for advice from a physician, pharmacist, or other qualified healthcare professional. Do not start, stop, combine, or change a prescribed medication solely because of information on this page.
Emergency information
If someone cannot be awakened, is breathing slowly or abnormally, or may be experiencing an opioid overdose, seek emergency medical help immediately and give naloxone if it is available.
Treatment-directory transparency
Some Rehabs.Today articles link to treatment directories and provider resources. Those links are for navigation and do not replace independent medical assessment. Medical claims in the article should be evaluated from the cited evidence, not from whether a treatment provider is linked.